Back

Long-term validation of AtherosSlerosis CardioVascular Disease (ASCVD) risk score and the role of aspirin for primary Cardiovascular prevention in Korean patients with over ASCVD 20% risk score

1 September 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Risk factors and characterisation of coronary artery disease Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Sujin Hyun

Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Undiagnosed impaired glucose tolerance/diabetes mellitus and relationship with aortic stiffness in patients with acute coronary syndromes
Doctor S. Chiusolo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Impact of systolic blood pressure on epicardial adipose tissue in patients with chronic coronary artery disease
Professor L. Zhong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Association of metabolic phenotypes with cardiovascular events in primary and secondary prevention
Doctor E. Steinacher (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Sleep disordered breathing and in-hospital prognosis in acute myocardial infarction patients: a subset of the AMI-Sleep study
Doctor P. Balagny (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Association between average glucose concentration or glucose variability and acute kidney injury among CAD patients with prediabetes
Doctor Y. Yan (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and characterisation of coronary artery disease

The Event

Event poster

ESC Congress 2024

1 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Clopidogrel versus aspirin monotherapy for secondary prevention after percutaneous coronary intervention - a nationwide population-based study
thumbnail
Congress Presentation
Aspirin for the primary prevention of major adverse cardiovascular events in patients with elevated lipoprotein(a): a meta-analysis
thumbnail
Congress Session
Improving pharmacotherapy in primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources